Event Type : Pathways Newsletter Events

The Catalyze Preclinical Services Program is now accepting Expressions of Interest (EOI) to support early translational product development in heart, lung, blood, and sleep research.

This program hosted by NHLBI and managed by RTI International,  and provides milestone-driven preclinical support for small molecules, biologics, devices, diagnostics, and technologies.

Interested applicants must submit an EOI by February 13, 2026, after which selected projects will be invited to submit a full application. To learn more about the Catalyze program, click here.

The TRISH Catalyst Program, hosted by the Translational Research Institute for Space Health (TRISH) in alignment with NASA’s Human Research Program, is now accepting proposals on a rolling basis to support high-impact, proof-of-concept and early technology development projects addressing critical human health risks for space exploration.

Catalyst is designed for U.S. universities, companies, and research organizations developing novel ideas, technologies, or countermeasures that fall outside currently open TRISH solicitations.  Funded projects are expected to begin in Spring/Summer 2026, with Tier 1 awards up to $150K for 12 months and Tier 2 awards of $150K+ for up to 18 months, subject to the availability of NASA funding.

The application deadline is February 18th, 2026. To learn more and begin your application, visit the webpage here.

FORGE is hosting a practical webinar on making intellectual property (IP) attractive to investors led by IP attorneys John Harmon and John Hovestadt of Wolf Greenfield. This online session is designed for startup founders, product innovators, executives, engineers, and business leaders preparing for fundraising, partnerships, or acquisitions. The webinar will cover how investors evaluate IP, strategies for building strong and defensible patent portfolios, protecting trade secrets, ensuring clear IP ownership, and avoiding common compliance pitfalls that can undermine valuation during diligence.

This event will take place on on February 25, 2026, from 10:30 AM–12:00 PM (ET). Register for this event and learn more here.

B2M Talks: Market Research Fundamentals is a free virtual session taking place on February 25 from 12:00–1:00 PM. Hosted as part of the Biolocity Bench2Market (B2M) Talks series, this event is designed for university researchers, innovators, and early-stage product developers seeking to better understand commercialization pathways for medical products.

The session will cover why market research is critical throughout the innovation and product lifecycle, introduce key market research methods and when to use them, and highlight how research can inform unmet needs, market sizing, and stakeholder priorities across the healthcare ecosystem.

ADVOCATE is a new ARPA-H funding opportunity focused on transforming cardiovascular care through agentic clinical AI. The Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program seeks teams from industry, academia, nonprofits, and small businesses to develop trusted, FDA-authorized AI agents that can provide continuous, autonomous cardiovascular care, while being safely monitored by a supervisory AI system after deployment.

A Solution Summary is due February 27, 2026, with Full Proposals due April 1, 2026 for teams encouraged to proceed. For more details, click here.